IGFBP-2 can also act intrinsically by interacting with integrin receptors, which can involve regulation of downstream effectors such as the tumour suppressor genes PTEN, STAT3, and NFκB [30,31,32]. The gene discussed is STAT3; the disease is neoplasm.